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Injuries to the meniscus are often treated by partial or total meniscectomy, which is known to be associated with detrimental changes in joint function, ultimately increasing the risk of early degenerative joint diseases (4) (5) (6) . Surgical approaches currently in use to substitute the damaged meniscus (e.g., the use of allografts or of a collagen-based material) can initially restore a stable and pain-free joint, but long-term clinical results, especially related to the protection of the articular surface, are still uncertain (7; 8) . Recently, tissue engineering strategies have been proposed for the generation of meniscus substitutes, based on the loading and culture of suitable cells into appropriate biodegradable porous scaffolds (9) (10) (11) (12) . The promising approach has been pre-clinically validated by several studies (11; 13), indicating the potential of cell-based meniscus substitutes to improve healing of meniscus tissue.
Several cell sources have been used for meniscus repair, including meniscus fibrochondrocytes (11; 12; 14; 15), chondrocytes (13; 16; 17) or bone marrow-derived mesenchymal progenitor cells (18) (19) (20) , but to the best of our knowledge a direct comparison of the different cell types has not yet been established. With the ultimate goal to identify an appropriate cell source for the generation of meniscus substitutes, the aim of our work was to compare the growth and post-expansion chondrogenic capacity of different cell types that would be readily available during meniscectomy or arthroscopic examination of an injured knee joint. In particular, we investigated the following human cell types: (i) inner meniscus cells (hereafter referred to as "meniscus cells"), which constitute the native target tissue and can be expanded even following meniscus injury (15) ; (ii) fat pad cells, known to include multipotent mesenchymal progenitor cells (21) ; (iii) synovial membrane cells, reported to have a progenitor nature (22; 23) and to be involved in healing of cartilage lesions (24; 25) ; and (iv) articular chondrocytes, currently in clinical use for articular cartilage repair and capable of differentiation into a variety of mesenchymal tissues (26) (27) (28) . All cells were expanded with or without growth factors previously reported to enhance chondrogenesis of different 3 chondrocyte types (29; 30) , and then induced to form 3D cartilaginous tissues in a scaffold-free model system (i.e., pellet culture), or using a hyaluronan-based scaffold, following in vitro culture or in vivo ectopic implantation. Each model included a culture phase in the presence of chondrogenic supplements, typically used to induce the expression of GAG and collagens (31; 32).
Tissues were assessed for the content of GAG, and the expression pattern of different collagen types was compared to that in the different regions of native human menisci.
Materials and Methods

Human material
Meniscus, fat pad and synovial membrane tissues were obtained from a total of 15 donors (26-68 years of age, mean 45), after informed consent. Biopsies were harvested during partial meniscectomy or anterior cruciate ligament reconstruction, no longer than 2 months after trauma.
At the time of surgery, knee joints were not overtly inflamed or osteoarthritic, although a few cases displayed minor inflammation (4/15 donors), ICRS Grade 1 cartilage damage (2/15 donors), or moderate osteoarthrosis (3/15 donors). Meniscus (n=15), fat pad (n=7) and synovial membrane (n=12) biopsies were all relatively small in size, with a weight range of respectively 10-500 mg, 10-100 mg, and 20-400 mg. Meniscus biopsies were only from the inner avascular region, where injured tissue is typically resected. Synovial membrane was from the suprapatellar recess and adipose tissue from the infrapatellar fat-pad. For ethical reasons, articular cartilage could not be harvested from the same donors. Cartilage tissues were thus collected from the medial femural condyle of 6 cadavers (22-55 years of age, mean 42), with no known clinical history of joint disorders, within 24 hours after death. Based on a preliminary study, the growth and differentiation ability of chondrocytes isolated from macroscopically normal cartilage shortly after knee joint trauma was within the range of chondrocytes isolated from cadaver joints. The weight range for the articular cartilage specimens was 500-1000 mg.
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Complete human meniscus specimens were also obtained with ethical permission and consent from 32 individuals made anonymous (18-86 years of age, mean 56), undergoing above knee amputation or partial meniscectomy for traumatic or degenerative tears. Complete meniscus specimens were processed for immunohistochemical analysis as described below and used to define the pattern of collagen types expressed in the deep inner avascular and deep outer vascularized regions of the native meniscus tissue. Analysis did not include characterization of the superficial fibroblastic layer of the meniscus.
Cell Isolation and Culture
Inner meniscus and articular cartilage biopsies were finely minced and digested by incubation for 22 hours at 37°C in 0.15% type II collagenase (Worthington Biochemical Corporation, Lakewood, NJ) (1ml solution per 100mg tissue) (33). Meniscus cells and articular chondrocytes were resuspended in Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L glucose with nonessential amino acids), containing 10% fetal bovine serum, 4.5 mg/mL glucose, 0.1mM nonessential amino acids, 1 mM sodium pyruvate, 100 mM HEPES buffer, 100 U/mL penicillin, 100 µg/mL streptomycin and 0.29 mg/mL L-glutamine (control medium).
Fat pad and synovial membrane biopsies were grossly cut and digested by incubation respectively for 7 hours and for 22 hours in 0.4% type II collagenase (1ml solution per 40mg tissue). For the isolation of fat pad cells, floating adipocytes were removed by centrifugation at 300g for 5 minutes (34) . Collagenase concentration and incubation times were selected by adapting a previously published protocol (22) , following preliminary tests.
Meniscus, fat pad, synovial membrane cells and articular chondrocytes were plated in tissue culture flasks, at a density of 10 4 cells/cm 2 , and cultured in a humidified incubator at 37°C and 5% CO 2 .
Throughout the phase of expansion in monolayer, all cell sources were cultured in control medium, without or with further supplementation of 1 ng/mL Transforming growth factor-β1 (TGF-β1), 5 ng/mL Fibroblast growth factor-2 (FGF-2) and 10 ng/mL Platelet-derived growth factor-bb (PDGFbb) (TFP medium). The growth factors (all from R&D Systems, Minneapolis, MN) were selected 5 based on their previously reported capacity to enhance the growth and post-expansion chondrogenic ability of different human chondrocyte types (29; 30) .
Differentiation assays
Upon reaching subconfluence, meniscus, fat pad, synovial membrane cells and articular chondrocytes were detached using 0.05% trypsin/ 0.53mM EDTA (GIBCO-BRL, CH) and replated at a density of 5x10 3 cells/cm 2 . Following an additional passage of expansion, cells were used in the three different models described below.
Model I: chondrogenic differentiation in 3D pellet culture Meniscus, fat pad, synovial membrane cells and articular chondrocytes from all donors, expanded with or without TFP, were suspended in a defined serum free medium, consisting of DMEM supplemented with ITS +1 (10 µg/mL insulin, 5.5 µg/mL transferrin, 5 ng/mL selenium, 0.5 µg/mL bovine serum albumin, 4.7 ng/mL linoleic acid, from Sigma Chemical, St Louis, MO), 1 mM sodium pyruvate, 100 mM HEPES buffer, 100 U/mL penicillin, 100 µg/mL streptomycin, 0.29 mg/mL L-glutamine, 0.1 mM ascorbic acid 2-phosphate, 1.25 mg/mL human serum albumin, 10 ng/mL TGF-β1 and 10 -7 M dexamethasone. The serum free medium was initially developed for the chondrocytic differentiation of human mesenchymal progenitor cells (35) and is typically used for the redifferentiation of human articular chondrocytes (29) . Aliquots of 5 x 10 5 cells in 0.5mL of serum free medium were centrifuged in 1.5 mL conical polypropylene tubes (Sarstedt, Nümbrecht, D) at 1300 rpm for 4 min to form spherical pellets. These were placed on a 3D orbital shaker (Bioblock Scientific, Frenkendorf, CH) at 30 rpm in a humidified incubator at 37°C and 5% CO 2 .
Pellets were cultured for 2 weeks, with medium changes twice per week, and subsequently processed for histological, immunohistochemical, biochemical or mRNA analysis as described below. Each analysis was performed independently in at least two entire pellets for each primary culture and expansion condition. (37) . Cells were resuspended in 28μL of control medium and slowly dispersed over the top surface of the dry meshes with a micropipette. The seeded scaffolds were transferred to a 37°C incubator to allow for initial cell attachment. After 45 minutes, 100 μL of medium were carefully added to the base of each well. After a further 1.5 hours of incubation, 2 mL of medium were slowly added along the side of each well to cover the scaffold. Cell-scaffold constructs were cultured in control medium supplemented with 1ng/ml of TGFβ-3, 0.1 mM ascorbic acid 2-phosphate and 10μg/ml of human insulin, with medium changes twice a week. After 2, 4 and 6 weeks, the resulting tissues were processed for histological, immunohistochemical, biochemical or mRNA analysis as described below. Each analysis was performed independently in at least three engineered tissues for each primary culture and cell source.
Model III: ectopic implantation in nude mice
Meniscus, fat pad, synovial membrane cells and articular chondrocytes from 1 donor, expanded with TFP, were loaded and cultured for 2 weeks into Hyaff ® -11 meshes as described for Model II and implanted subcutaneously in nude mice (CD-1 nude/nude, Charles River, Germany). After 6 weeks, mice were euthanised and explants processed for histological, immunohistochemical, biochemical or mRNA analysis as described below. Each analysis was performed independently in two engineered tissues for each cell source.
Analytical methods
Proliferation rate during expansion
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The number of doublings of meniscus, fat pad, synovial membrane cells and articular chondrocytes during the second passage of expansion was determined as the logarithm in base 2 of the fold increase in the number of cells during expansion. The proliferation rate was defined as the number of doublings during the second passage of expansion divided by the time required for expansion and was expressed as doublings/day.
Real time RT-PCR (global amplification)
Total RNA was prepared from pellet cultures using Tri-Reagent (Sigma, UK). Pellet cultures were ground up in the Tri-Reagent using Molecular Grinding Resin (Geno Technology Inc, St Louis, USA). cDNA was synthesised from 10-100ng of total RNA by global amplification (38) . Globally amplified cDNA was diluted 1:1000 and 1µl aliquots of the diluted cDNA were amplified by real time RT-PCR in a 25μl reaction volume on a MJ Research Opticon using a SYBR Green Core Kit (Eurogentec, Seraing, Belgium), with gene specific primers designed using ABI Primer Express software. Relative expression levels were normalised using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and calculated using the 2 -ΔCt method (39) . All primers were from AGAGAAAGAAAAAGGGAAAGGTAAGTTT. The expression levels of collagen types I, II and SOX-9 were investigated to determine the relative extent of cell differentiation towards a fibrocartilaginous or hyaline-like phenotype.
Biochemistry
Tissues generated by meniscus, fat pad, synovial membrane cells and articular chondrocytes were digested with protease K (1mg/mL protease K in 50 mM Tris with 1 mM EDTA, 1 mM 8 iodoacetamide, and 10 mg/mL pepstatin-A; 0.5 mL solution for cell pellets and 1mL for Hyaff
based constructs) for 15 h at 56°C (34) . The glycosaminoglycan (GAG) content was measured spectrophotometrically using dimethylmethylene blue (40) , with chondroitin sulfate as a standard, and normalized to the DNA amount, measured using the CyQUANT cell proliferation assay kit (Molecular Probes, Eugene, OR), with calf thymus DNA as a standard.
Histology
Tissues were rinsed in PBS, fixed in 4% buffered formalin for 24 h at 4°C, embedded in paraffin, and sectioned to a thickness of 5 µm for cell pellets and of 7 µm for Hyaff ® -11 based constructs.
Sections were stained with Safranin-O for sulfated GAG.
Immunohistochemistry
Cryostat sections (3 to 5 µm thick) were cut from tissues and pellets stored frozen at -70°C. 
Statistical Analysis
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Values are presented as mean ± standard deviation. Differences between the experimental groups were evaluated by Mann Whitney U tests and considered statistically significant with p < 0.05.
Results
Characterization of native human meniscus
The inner and outer regions of human native meniscus displayed a uniformly positive immunohistochemical staining for collagen types I, III and VI. Instead, staining for collagen type II, the major fibril collagen in articular cartilage, was weakly positive only in the inner meniscus region. Staining for collagen type IV, usually absent from articular cartilage, was positive, predominantly in a dendritic pattern, in the outer vascular zone of the meniscus and also, but to a lower extent, in the inner meniscus (Table I , section A), as previously described for ovine meniscus (41) .
Cell proliferation during monolayer expansion
Meniscus, fat pad, synovial membrane cells and articular chondrocytes cultured in control medium proliferated at similar rates (Fig. 1) . However, probably due to the limited biopsy size (i.e., if lower than 20 mg), some cultures of meniscus (three primaries), fat pad (four primaries) and synovial membrane cells (one primary) could not be expanded.
TFP supplementation during expansion significantly increased the proliferation rate of all four cell types, and allowed cell expansion even in cases of limited biopsy size. In the presence of TFP, articular chondrocytes proliferated significantly faster than all other cell sources.
Model I: 3D pellet cultures
After two weeks of culture, meniscus, synovial membrane cells and articular chondrocytes expanded in control medium formed spherical pellets, in contrast to fat pad cells, which did not generate regular tissue structures (Fig. 2) . Following expansion in control medium, only articular chondrocytes generated tissues positively stained for GAG. Medium supplementation with TFP during expansion of all cell sources resulted in pellets more intensely stained for GAG. A chondrocytic cell morphology and overtly positive staining for GAG was observed in pellets generated by articular chondrocytes and in restricted regions of pellets generated by fat pad and synovial membrane cells.
Pellets generated by all cell sources, expanded with or without TFP, contained similar amounts of DNA (data not shown). Following expansion in control medium, articular chondrocytes generated pellets with significantly higher GAG/DNA fractions than the other cell sources (Fig. 3A) . Medium Following TFP expansion and differentiation in pellets, articular chondrocytes expressed mRNA levels of SOX-9 higher than all other cell sources and of collagen type II higher than meniscus and synovial membrane cells.
Pellets generated by all cell sources displayed positive immunohistochemical staining for collagen types I, III, IV and VI, with generally increased levels of staining following TFP expansion (Table   I, (42)). Histological staining of tissue cross-sections indicated that only articular chondrocytes were able after 6 weeks to engineer cartilaginous tissues positively stained for GAG (Fig. 4) .
The pattern of collagen types deposited in cell-Hyaff ® -11 constructs was similar to that described in cell pellets (Table I , section C). In particular, tissues generated by articular chondrocytes were positively stained for all assessed collagen types, including collagen type II, thus indicating a hybrid fibro-hyaline cartilaginous nature (Fig. 5) . Instead, tissues formed by meniscus, fat pad and synovial membrane cells were negatively stained for collagen type II.
Model III: ectopic implantation following culture into Hyaff
® -11 meshes
In order to assess the intrinsic capacity of engineered cartilage tissues to further develop upon implantation in an environment supportive, but not inductive, of chondrogenesis (43), constructs generated by all cell sources, following two weeks of pre-culture in vitro (44) , were implanted in subcutaneous pockets in nude mice for 6 weeks. Following in vivo implantation, the DNA content decreased and reached similar levels in all constructs (between 0.030% and 0.047% of the wet weight). In parallel, the GAG content increased in all constructs, and reached the highest levels in tissues generated by articular chondrocytes (1.4 ± 0.3% of the wet weight, respectively 2.6-, 1.9-and 3.5-fold higher than in tissues formed by meniscus, fat pad and synovial membrane cells).
Histologically, tissues formed by articular chondrocytes were qualitatively similar to those maintained in culture for a total of 6 weeks (Model II), with a mixture of fibroblastic and chondrocytic cell phenotypes, large intercellular spaces positively stained for GAG, and no evidence of vascularization (Fig. 6) . Instead, tissues formed by meniscus, fat pad and synovial membrane cells contained mostly fibroblastic cells and negligible extracellular matrix, with no detectable positive stain for GAG. As compared to articular chondrocytes-based constructs, the lower amount of extracellular matrix in meniscus-, fat pad-and synovial membrane cells-based tissues appeared to be associated with a more advanced degradation of the esterified hyaluronan fibers, which were markedly more swollen, likely due to increased absorption of water (Fig. 6 ).
Immunohistological staining of explant cross-sections indicated that tissues generated by articular chondrocytes were positively stained for all assessed collagen types, including type II (Table I, section D). Instead, the amount of extracellular matrix in meniscus-, fat pad-and synovial membrane cells-based tissues was too limited to allow for reliable immunohistochemical characterization.
Discussion
In this study, with the ultimate goal of identifying a suitable cell source for engineering autologous meniscus grafts, we compared the growth and post-expansion chondrogenic capacity of human meniscus, fat pad, synovial membrane cells and articular chondrocytes using three different model systems. Our results indicate that (i) articular chondrocytes reached the highest proliferation rates and (ii) only tissues formed by expanded articular chondrocytes contained molecules typically found in the inner avascular region of the meniscus (i.e., GAG and collagen type II), in the outer vascularized region of the meniscus (i.e., collagen type IV), and common to both regions (i.e., collagen types I, III and VI). Instead, under our specific experimental setup, tissues formed by meniscus, fat pad, and synovial membrane cells contained negligible GAG amounts and no detectable collagen type II.
We initially studied the response of the different cell sources to a specific growth factor combination (i.e., TFP) supplemented during cell expansion. Medium supplementation with TFP induced a significant increase in the proliferation rate during expansion and in the deposition of GAG in pellet cultures by all cell sources. In addition, it induced an upregulation of the mRNA levels of collagen type II in pellet cultures by fat pad and synovial membrane cells. We previously 13 reported that in addition to articular chondrocytes (29) , also chondrocytes from ear and nasal septum increased their growth and post-expansion ability to generate cartilaginous tissues in response to TFP (30) . The fact that different chondroprogenitor cells and mature chondrocytes from different cartilage sources similarly responded to the TFP growth factor combination during expansion suggests that these different cell types share certain pathways controlling chondrogenic commitment; in this context, it would be interesting to assess which common specific gene sets are up-or down-regulated in the different cell sources when exposed to TFP. Although we cannot exclude that different experimental conditions (e.g., use of different sets of growth factors) might result in a different trend, data generated using the described model systems indicate that articular chondrocytes represent a more appropriate cell source than meniscus, fat pad or synovial membrane cells for the generation of a meniscus substitute. Recent studies have already explored the possibility to heal lesions in the avascular region of the meniscus using lamb (16) or swine articular chondrocytes (17) , with promising results. Clearly, tissues engineered by articular chondrocytes only remotely mimic the complex structure of native meniscus; moreover, in our study we have not investigated the spatial organization of aggrecan or of collagen fibers, which is known to be highly specific in meniscus cartilage (54; 55) . In this regard, it should be pointed out that differential localization of specific matrix molecules in articular chondrocytes-based tissues may be induced by appropriate physical conditioning in vitro, e.g. by application of hydrodynamic forces (Marsano et al., Biorehology, In Press). Moreover, it is likely that the composition and mechanical properties of the graft will correctly develop by adapting to local mechanical forces upon implantation, as it is described during the process of embryonic joint development (56) (57) (58) . In this context, studies are ongoing in a sheep model to assess the efficacy of autologous articular chondrocytes loaded into appropriately shaped scaffolds as engineered substitutes for total meniscectomies. weeks, followed by 6 weeks of ectopic implantation. Bar = 300 µm. 
